Kantarjian H, Branford S, Breccia M, Cortes J, et al. Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? Leukemia 2024 Mar 26. doi: 10.1038/s41375-024-02229.
PMID: 38531949